MedTrace Logo

Anesthetics to Prevent Lung Injury in Cardiac Surgery

NCT02918877 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2021-05-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate whether the use of inhaled anesthetics, compared to intravenous anesthetics, can affect the amount of lung inflammation and postoperative respiratory complications seen after cardiac surgery.

Conditions

  • Inflammatory Lung Injury
  • Ischemia-Reperfusion Lung Injury
  • Postoperative Pulmonary Complications

Interventions

DRUG

Sevoflurane

Volatile Anesthetic

DRUG

Propofol

Intravenous Anesthetic

Sponsors & Collaborators

Principal Investigators

  • Brian O'Gara, MD · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-09
Primary Completion
2018-12-24
Completion
2021-02-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02918877 on ClinicalTrials.gov